Prescribing, Policies and Pathways
The last day of operation for Hertfordshire and West Essex ICB was 31 March 2026. The information on this website has not been updated since 31 March 2026. The legacy policies, prescribing recommendations and pathways can be accessed on this website. Find out more
or
| Medicine / Guideline | Indication | RAG rating | Document type | Place |
|---|---|---|---|---|
| Anagrelide | Reduction of elevated platelet counts | Red | n/a | Hertfordshire and West Essex ICB |
| Avatrombopag | Primary chronic immune thrombocytopenia | Red | Decision document | Hertfordshire and West Essex ICB |
| Avatrombopag | Thrombocytopenia in chronic liver disease | Red | NICE technology appraisal | Hertfordshire and West Essex ICB |
| Dalteparin | Anticoagulation | Red | n/a | Hertfordshire and West Essex ICB |
| Darbepoetin | Anaemia with chemotherapy (NHSE) | Red | NICE technology appraisal | Hertfordshire and West Essex ICB |
| Darbepoetin | Anaemia with chronic kidney disease | Red | Decision document | Hertfordshire and West Essex ICB |
| Deep Vein Thrombosis (DVT) | n/a | Clinical pathways | East and North Hertfordshire | |
| Deferasirox | Blood transfusion related iron overload in patients with myelodysplastic syndrome | Double Red | Decision document | Hertfordshire and West Essex ICB |
| Deferiprone | Blood transfusion related iron overload in patients with myelodysplastic syndrome | Double Red | Decision document | Hertfordshire and West Essex ICB |
| Desferrioxamine | Blood transfusion related iron overload in patients with myelodysplastic syndrome | Double Red | Decision document | Hertfordshire and West Essex ICB |
| DOAC (best value DOAC - 1st line generic apixaban & rivaroxaban) | Treatment of deep vein thrombosis (DVT) or pulmonary embolism (PE) and prevention of recurrent DVT and PE | Amber initiation | n/a | Hertfordshire and West Essex ICB |
| Eltrombopag | Thrombocytopenia related to hepatitis C | Red | Decision document | Hertfordshire and West Essex ICB |
| Eltrombopag | Aplastic anaemia | Double Red | NICE technology appraisal | Hertfordshire and West Essex ICB |
| Eltrombopag ITP | Chronic immune thrombocytopenia | Red | NICE technology appraisal | Hertfordshire and West Essex ICB |
| Enoxaparin | Anticoagulation | Red | n/a | Hertfordshire and West Essex ICB |
| Epoetin | Anaemia with chronic kidney disease | Red | Decision document | Hertfordshire and West Essex ICB |
| Epoietin | Anaemia with chemotherapy (NHSE) | Red | NICE technology appraisal | Hertfordshire and West Essex ICB |
| Erythropoiesis stimulating agents | Anaemia with chronic kidney disease | Red | Decision document | Hertfordshire and West Essex ICB |
| Ferric maltol | Iron deficiency | Double Red | n/a | Hertfordshire and West Essex ICB |
| Filgrastim | Neutropenia (NHSE) | Red | NICE technology appraisal | Hertfordshire and West Essex ICB |
| Fondaparinux | Thrombosis | Red | n/a | Hertfordshire and West Essex ICB |
| Fostamatinib | Chronic immune thrombocytopenia | Red | NICE technology appraisal | Hertfordshire and West Essex ICB |
| Hydroxycarbamide | Sickle Cell Disease | Red | n/a | Hertfordshire and West Essex ICB |
| Hydroxycarbamide | Myeloproliferative neoplasms | Amber protocol | Shared care protocol | Hertfordshire and West Essex ICB |
| Iron chelators | Blood transfusion related iron overload in patients with myelodysplastic syndrome | Double Red | Decision document | Hertfordshire and West Essex ICB |
| Lenograstim | Neutropenia (NHSE) | Red | NICE technology appraisal | Hertfordshire and West Essex ICB |
| Low molecular weight heparin (LMWH) | Anticoagulation | Red | Decision document | Hertfordshire and West Essex ICB |
| Lusutrombopag | Thrombocytopenia in chronic liver disease | Red | NICE technology appraisal | Hertfordshire and West Essex ICB |
| Pegfilgrastim | Neutropenia (NHSE) | Red | NICE technology appraisal | Hertfordshire and West Essex ICB |
| Peginterferon and ropeginterferon | Myeloproliferative neoplasms (NHSE) | Red | Decision document | Hertfordshire and West Essex ICB |
| Rituximab | Autoimmune haemolytic anaemia (AIHA) | Red | Decision document | Hertfordshire and West Essex ICB |
| Romiplostim | Chronic immune thrombocytopenia | Red | NICE technology appraisal | Hertfordshire and West Essex ICB |
| Roxadustat | Anaemia with chronic kidney disease | Red | Decision document | Hertfordshire and West Essex ICB |
| Ruxolitinib | Polycythaemia vera (NHSE) | Red | NICE technology appraisal | Hertfordshire and West Essex ICB |
| Vitamin & mineral RAG rating - Iron dextran | Iron deficiency | Red | n/a | Hertfordshire and West Essex ICB |